Clincosm LogoSign in Get a demo

Atopic Dermatitis

Showing 1 - 25 of 813
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atopic Dermatitis Trial in Canada, United States (Oral EP262, Placebo)

Recruiting
  • Atopic Dermatitis
  • Oral EP262
  • Placebo
  • Birmingham, Alabama
  • +9 more
Nov 28, 2023

Atopic Dermatitis Trial

Not yet recruiting
  • Atopic Dermatitis
    • (no location specified)
    Nov 16, 2023

    Atopic Dermatitis Trial in Helsinki (Nature-based exposure by biodiversity component in lotion., Placebo group using colored

    Active, not recruiting
    • Atopic Dermatitis
    • Nature-based exposure by biodiversity component in lotion.
    • Placebo group using colored lotion.
    • Helsinki, Finland
      Uute Scientific Oy
    Nov 8, 2023

    Healthy, Atopic Dermatitis Trial in Daytona Beach (LY3872386, Prednisone, Placebo)

    Not yet recruiting
    • Healthy
    • Atopic Dermatitis
    • Daytona Beach, Florida
      Fortrea Clinical Research Unit
    Nov 1, 2023

    Atopic Dermatitis Trial (Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose)

    Not yet recruiting
    • Atopic Dermatitis
    • Dupilumab - Discontinuation
    • +2 more
    • (no location specified)
    Nov 2, 2023

    Atopic Dermatitis Trial (CM310)

    Not yet recruiting
    • Atopic Dermatitis
    • CM310
    • (no location specified)
    Oct 30, 2023

    Atopic Dermatitis Trial (Cosmetic Product TOPIALYSE Baume Protect+)

    Not yet recruiting
    • Atopic Dermatitis
    • Cosmetic Product TOPIALYSE Baume Protect+
    • (no location specified)
    Oct 25, 2023

    Atopic Dermatitis, Eczema Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Roseomonas mucosa

    Not yet recruiting
    • Atopic Dermatitis
    • Eczema
    • Roseomonas mucosa (RSM2015) and Cardamom seeds
    • Placebo (sucrose)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 27, 2023

    Atopic Dermatitis Trial in Canada, United States (OpSCF, Placebo, OpSCF (Open Label Extension))

    Not yet recruiting
    • Atopic Dermatitis
    • OpSCF
    • +2 more
    • Birmingham, Alabama
    • +15 more
    Oct 25, 2023

    Atopic Dermatitis Trial in China (AK120)

    Not yet recruiting
    • Atopic Dermatitis
    • Hefei, Anhui, China
    • +25 more
    Oct 16, 2023

    Atopic Dermatitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )

    Completed
    • Atopic Dermatitis
    • LNK01001 Dose A
    • +2 more
    • Beijing, China
      Jianzhong Zhang
    Oct 10, 2023

    Hidradenitis Suppurativa, Atopic Dermatitis, Healthy Volunteer Trial (LT-002-158/Placebo oral tablet(s))

    Not yet recruiting
    • Hidradenitis Suppurativa
    • +2 more
    • LT-002-158/Placebo oral tablet(s)
    • (no location specified)
    Oct 9, 2023

    Periodontal Status in Patients With Chronic Skin Diseases

    Completed
    • Periodontal Diseases
    • +4 more
    • oral health status
    • Ho Chi Minh City, Vietnam
      University of Medicine and Pharmacy at Ho Chi Minh city
    Oct 5, 2023

    Food-specific IgG4-guided Elimination Diets Improve Allergy

    Completed
    • Rhinitis, Allergic
    • +4 more
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital，School of Medicine，Zhejiang Universit
      Sep 25, 2023

      Atopic Dermatitis Trial in Shenyang, Jinan (1.5% QLM3003, 2% QLM3003, Vehicle (Placebo))

      Not yet recruiting
      • Atopic Dermatitis
      • 1.5% QLM3003
      • +2 more
      • Shenyang, Liaoning, China
      • +1 more
      Sep 21, 2023

      Atopic Dermatitis Trial (SAR444656 (KT-474), Placebo)

      Not yet recruiting
      • Atopic Dermatitis
      • SAR444656 (KT-474)
      • Placebo
      • (no location specified)
      Sep 21, 2023

      Atopic Dermatitis Trial in North Little Rock, Camp Hill, Philadelphia (BxC-I17e, Placebo)

      Recruiting
      • Atopic Dermatitis
      • North Little Rock, Arkansas
      • +2 more
      Sep 20, 2023

      Atopic Dermatitis Trial (BxC-I17e, Placebo)

      Not yet recruiting
      • Atopic Dermatitis
      • (no location specified)
      Sep 20, 2023

      Dupilumab in Participants =6 Years With Atopic Dermatitis

      Recruiting
      • Atopic Dermatitis
        • Berlin, Germany
          Investigational Site Number :
        Sep 18, 2023

        Atopic Dermatitis in Premature Infants

        Completed
        • Atopic Dermatitis
        • Lacticaseibacillus rhamnosus
        • Lactobacillus acidophilus + Bifidobacterium bifidum
        • (no location specified)
        Sep 6, 2023

        Atopic Dermatitis Trial in China (AK120, Placebo)

        Recruiting
        • Atopic Dermatitis
        • Bengbu, Anhui, China
        • +38 more
        Sep 6, 2023

        Atopic Dermatitis Trial in Hellerup (flexible patient centred consultations)

        Recruiting
        • Atopic Dermatitis
        • flexible patient centred consultations
        • Hellerup, Copenhagen, Denmark
          Gentofte University Hospital
        Sep 4, 2023

        Atopic Dermatitis Trial in Shanghai (MG-K10/Placebo)

        Active, not recruiting
        • Atopic Dermatitis
        • MG-K10/Placebo
        • Shanghai, China
          Huashan Hospital Affiliated to Fudan University
        Aug 31, 2023

        Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp Trial (HY209GEL Active, Placebo)

        Not yet recruiting
        • Atopic Dermatitis
        • +2 more
        • HY209GEL Active
        • Placebo
        • (no location specified)
        Aug 31, 2023

        Topical Cannabidiol (CBD) Products for Atopic Dermatitis

        Recruiting
        • Atopic Dermatitis
        • Phoilex Releaf Gel
        • Brampton, Ontario, Canada
          Phoenix Medical Spa X Peak Human
        Aug 28, 2023